Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vitoc Vlad

(Last)

(First)

(Middle)

444 WEST LAKE STREET,

(Street)

CHICAGO

60606

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MAIA Biotechnology, Inc. [ MAIA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options	$1.8	11/05/2024		G⁽¹⁾			19,981	04/30/2020	04/01/2030	Common Stock	19,981	$1.8	149,519	D
Stock Options	$1.8	11/05/2024		G⁽¹⁾		19,981		11/05/2024	04/01/2030	Common Stock	19,981	$1.8	19,981	I	See footnote⁽²⁾
Stock Options	$1.8	11/05/2024		G⁽³⁾			19,982	04/30/2020	04/01/2030	Common Stock	19,982	$1.8	129,537	D
Stock Options	$1.8	11/05/2024		G⁽³⁾		19,982		11/05/2024	04/01/2030	Common Stock	19,982	$1.8	19,982	I	See footnote⁽⁴⁾
Stock Options	$1.8	11/05/2024		G⁽⁵⁾			19,982	04/30/2020	04/01/2030	Common Stock	19,982	$1.8	109,555	D
Stock Options	$1.8	11/05/2024		G⁽⁵⁾		19,982		11/05/2024	04/01/2030	Common Stock	19,982	$1.8	19,982	I	See footnote⁽⁶⁾
Stock Options	$2.5	11/05/2024		G⁽⁷⁾			41,254	05/31/2023	05/30/2033	Common Stock	41,254	$2.5	82,506	D
Stock Options	$2.5	11/05/2024		G⁽⁷⁾		41,254		11/05/2024	05/30/2033	Common Stock	41,254	$2.5	41,254	I	See footnote⁽⁸⁾
Stock Options	$2.5	11/05/2024		G⁽⁹⁾			41,253	05/31/2023	05/30/2033	Common Stock	41,253	$2.5	41,253	D
Stock Options	$2.5	11/05/2024		G⁽⁹⁾		41,253		11/05/2024	05/31/2033	Common Stock	41,253	$2.5	41,253	I	See footnote⁽¹⁰⁾
Stock Options	$2.5	11/05/2024		G⁽¹¹⁾			41,253	05/31/2023	05/30/2033	Common Stock	41,253	$2.5	0	D
Stock Options	$2.5	11/05/2024		G⁽¹¹⁾		41,253		11/05/2024	05/31/2033	Common Stock	41,253	$2.5	41,253	I	See footnote⁽¹²⁾

Explanation of Responses:

1. This transaction involves the reporting person's gift of 19,981 shares of MAIA Biotechnology, Inc.'s (the "Company") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

2. These securities are held by Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

3. This transaction involves the reporting person's gift of 19,982 shares of MAIA Biotechnology, Inc.'s (the "Company") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child. The reporting person disclaims beneficial ownership of these securities held by his daughter.

4. These securities are held by Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child. The reporting person disclaims beneficial ownership of these securities held by his daughter.

5. This transaction involves the reporting person's gift of 19,982 shares of MAIA Biotechnology, Inc.'s (the "Company") common stock held in options granted (which options fully vested on April 30, 2020) under the Company's 2018 Stock Option Plan to the Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

6. These securities are held by Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

7. This transaction involves the reporting person's gift of 41,254 shares of MAIA Biotechnology, Inc.'s (the "Company") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan) to the Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

8. These securities are held by Leia Violeta Ioana Vitoc 2022 MAIA Irrevocable Trust for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

9. This transaction involves the reporting person's gift of 41,253 shares of MAIA Biotechnology, Inc.'s (the "Company") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan to the Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as the trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

10. These securities are held by Maia Laetitia Cristian Vitoc 2022 MAIA Irrevocable Trust for the benefit of Mr. Vitoc's child, for which Mr. Vitoc's spouse serves as trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

11. This transaction involves the reporting person's gift of 41,253 shares of MAIA Biotechnology, Inc.'s (the "Company") common stock held in options granted (which options fully vested on May 31, 2023) under the Company's 2021 Stock Option Plan to the Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child. The reporting person disclaims beneficial ownership of these securities held by his daughter.

12. These securities are held by Lidia Maria Vitoc 2024 MAIA Irrevocable Trust, for the benefit of Mr. Vitoc's child. The reporting person disclaims beneficial ownership of these securities held by his daughter.

	/s/ Vlad Vitoc	11/06/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.